Study design and rationale of the heterotopic implantation of the Edwards‐Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial
Brian O’Neill(Henry Ford Health System), Howard Cohen(Cardiovascular Research Foundation), Paul R. Forfia(Temple University Hospital), Grayson H. Wheatley(Arizona Heart Institute), William W. O’Neill(Henry Ford Health System), Riyaz Bashir(Lankenau Heart Institute), Pravin Patil(Ruby Hall Clinic), Andrew Chen(Lankenau Heart Institute), Brian O’Murchu, Daniel Edmundowicz(Temple University Hospital)
Cited by 44
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
|New England Journal of Medicine|1987|945
Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts
|The Annals of Thoracic Surgery|2008|855
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
|European Heart Journal|2014|540
A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial Infarction
|New England Journal of Medicine|1986|504